Added to YB: 2026-02-11
Pitch date: 2026-02-09
HIMS [neutral]
Hims & Hers Health, Inc.
-15.4%
current return
Author Info
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$3.7B
Pitch Price
$18.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
23.63
P/E
30.31
EV/Sales
1.90
Sector
Health Care Providers and Services
Category
special_situation
HIMS: Napoleon Watches Moscow Burn
HIMS (update - short): Analysts warned CEO Andrew Dudum was pushing compounding GLP-1 loophole too far. After launching knock-off Wegovy pill with no clinical data, FDA specifically called out HIMS & HHS referred company to DOJ for potential criminal violations of Federal Food, Drug & Cosmetic Act. Stock -15% AH.
Read full article (4 min)